I agree that this site is using cookies. You can find further informations here.
X
Tsimafeyeu, I.
34  results:
Search for persons X
?
1

Avelumab and axitinib in metastatic renal cell carcinoma: R..:

Baklanova, O. ; Chubenko, V. ; Kalpinskiy, A....
European Urology Open Science.  57 (2023)  - p. S232 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Interim results from a real-world ambispective study RAVE-B..:

Anzhiganova, Y. ; Gridneva, Y. ; Sultanbayev, A....
European Urology Open Science.  57 (2023)  - p. S314 , 2023
Link: https://doi.org/10.1016/..
 
?
3

16P High fibrinogen levels affect the clinical outcomes of ..:

Tsimafeyeu, I. ; Volkova, M.I. ; Utyashev, I...
Immuno-Oncology and Technology.  16 (2022)  - p. 100121 , 2022
Link: https://doi.org/10.1016/..
 
?
4

A phase 2 study of intrapleural instillation of the nivolum..:

Tsimafeyeu, I. ; Goutnik, V. ; Shrainer, I...
European Urology Open Science.  33 (2021)  - p. S338 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Nivolumab in metastatic renal cell carcinoma (mRCC) patient..:

Tsimafeyeu, I. ; Protsenko, S. ; Gafanov, R....
European Urology Supplements.  18 (2019)  11 - p. e3518-e3519 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Phase 1b study of stereotactic body radiation therapy in co..:

Mitin, T. ; Dengina, N. ; Gamayunov, S....
International Journal of Radiation Oncology*Biology*Physics.  104 (2019)  5 - p. 1191 , 2019
Link: https://doi.org/10.1016/..
 
?
7

Radiation Therapy for Hepatocellular Carcinoma in Russia: A..:

Chernich, M. ; Dengina, N. ; Degnin, C....
International Journal of Radiation Oncology*Biology*Physics.  102 (2018)  3 - p. e387 , 2018
Link: https://doi.org/10.1016/..
 
?
8

FGFR2 overexpression predicts survival outcome in patients ..:

Tsimafeyeu, I. ; Khasanova, A. ; Stepanova, E....
Clinical and Translational Oncology.  19 (2016)  2 - p. 265-268 , 2016
Link: https://doi.org/10.1007/..
 
?
9

476 FGFR2 targeting with allosteric inhibitor RPT835:

Tsimafeyeu, I. ; Daeyaert, F. ; Yin, W....
European Journal of Cancer.  50 (2014)  - p. 155 , 2014
Link: https://doi.org/10.1016/..
 
?
10

O4 FGF- and VEGF-dependent angiogenesis and its targeting:

Tsimafeyeu, I. ; Wynn, N. ; Zaveleva, E..
European Urology Supplements.  12 (2013)  6 - p. 126 , 2013
Link: https://doi.org/10.1016/..
 
?
11

305 Does dose-dependent targeting of fibroblast growth fact..:

Tsimafeyeu, I. ; Zaveleva, E. ; Tolkacheva, T.
European Urology Supplements.  11 (2012)  1 - p. e305 , 2012
Link: https://doi.org/10.1016/..
 
?
12

27 Quality of life in metastatic renal cell carcinoma patie..:

Tsimafeyeu, I.
Critical Reviews in Oncology/Hematology.  78 (2011)  - p. S22 , 2011
Link: https://doi.org/10.1016/..
 
?
13

7116 Expression of fibroblast growth factor receptors 1 and..:

Tsimafeyeu, I. ; Demidov, L. ; Stepanova, E..
European Journal of Cancer Supplements.  7 (2009)  2 - p. 427-428 , 2009
Link: https://doi.org/10.1016/..
 
?
14

PHASE II STUDY OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) IN CO..:

Demidov, L. ; Tsimafeyeu, I. ; Madzhuga, A.
European Urology Supplements.  7 (2008)  3 - p. 307 , 2008
Link: https://doi.org/10.1016/..
 
?
15

PO-53 Phase II study of low molecular weight heparin (LMWH)..:

Tsimafeyeu, I. ; Madzhuga, A. ; Demidov, L...
Thrombosis Research.  120 (2007)  - p. S162 , 2007
Link: https://doi.org/10.1016/..
 
1-15